Sangamo Therapeutics, Inc. revenue breakdown overview

Sangamo Therapeutics, Inc. revenue for the last year amounted to 57.80 M USD, the most of which — 57.80 M USD — came from its highest performing source at the moment, Epigenetic, the year earlier bringing 176.23 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sangamo Therapeutics, Inc. 57.80 M USD, and the year before that — 176.23 M USD.